{"organizations": [], "uuid": "fd29276dd532ea1ae59e2c8ca673fbdd73fea0e3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180129.html", "section_title": "Archive News &amp; Video for Monday, 29 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-aspen-says-to-review-global-nutrit/brief-aspen-says-to-review-global-nutritionals-business-idUSFWN1PO0JU", "country": "US", "domain_rank": 408, "title": "BRIEF-Aspen Says To Review Global Nutritionals Business", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-29T18:06:00.000+02:00", "replies_count": 0, "uuid": "fd29276dd532ea1ae59e2c8ca673fbdd73fea0e3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-aspen-says-to-review-global-nutrit/brief-aspen-says-to-review-global-nutritionals-business-idUSFWN1PO0JU", "ord_in_thread": 0, "title": "BRIEF-Aspen Says To Review Global Nutritionals Business", "locations": [], "entities": {"persons": [], "locations": [{"name": "aspen", "sentiment": "none"}, {"name": "uk", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "aspen pharmacare holdings ltd", "sentiment": "negative"}, {"name": "centerview", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 29 (Reuters) - Aspen Pharmacare Holdings Ltd:\n* STRATEGIC REVIEW OF ASPEN’S GLOBAL NUTRITIONALS BUSINESS * ‍HAS BEEN EXPLORING OPTIONS TO ENHANCE VALUE OF ITS GLOBAL NUTRITIONALS BUSINESS (“NUTRITIONALS”) SINCE RECEIVING AN UNSOLICITED APPROACH IN Q3 OF LAST YEAR​\n* ‍CFDA OF REGISTRATION OF ASPEN‘S INFANT MILK FORMULA BRAND, ALULA, ASPEN HAS DECIDED TO FORMALISE ITS REVIEW OF STRATEGIC OPTIONS FOR NUTRITIONALS​\n* ‍RANGE OF OPTIONS WILL BE CONSIDERED INCLUDING, INTER ALIA, INTRODUCTION OF A STRATEGIC PARTNER THAT COULD UNLOCK APPROPRIATE VALUE​\n* ‍APPOINTED CENTERVIEW PARTNERS UK LLP AS FINANCIAL ADVISOR TO ASSIST IN STRATEGIC REVIEW PROCESS​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-29T18:06:00.000+02:00", "crawled": "2018-01-30T18:48:35.000+02:00", "highlightTitle": ""}